Stevanato Group (NYSE:STVN) PT Lowered to $22.00

Stevanato Group (NYSE:STVN) had its price target lowered by Morgan Stanley from $26.00 to $22.00 in a research report issued on Monday, Benzinga reports. The firm presently has an “equal weight” rating on the stock.

Other research analysts have also issued research reports about the stock. BNP Paribas initiated coverage on shares of Stevanato Group in a research note on Monday, April 22nd. They set an “outperform” rating for the company. Stephens restated an “overweight” rating and set a $38.00 price target on shares of Stevanato Group in a research note on Monday, March 25th. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, Stevanato Group presently has a consensus rating of “Moderate Buy” and an average target price of €32.83 ($35.69).

Stevanato Group Stock Performance

NYSE STVN opened at €22.02 ($23.93) on Monday. The company has a current ratio of 1.92, a quick ratio of 1.35 and a debt-to-equity ratio of 0.21. The company has a 50 day moving average price of €19.42 and a 200 day moving average price of €26.15. Stevanato Group has a 52 week low of €16.56 ($18.00) and a 52 week high of €36.30 ($39.46).

Stevanato Group (NYSE:STVN) last posted its quarterly earnings data on Thursday, May 9th. The company reported €0.09 ($0.10) EPS for the quarter, missing the consensus estimate of €0.12 ($0.13) by (€0.03) (($0.03)). The firm had revenue of €256.24 million for the quarter, compared to the consensus estimate of €261.28 million. Stevanato Group had a return on equity of 12.61% and a net margin of 12.57%. Equities research analysts predict that Stevanato Group will post 0.53 earnings per share for the current fiscal year.

Institutional Trading of Stevanato Group

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. SRS Capital Advisors Inc. grew its position in Stevanato Group by 327.1% during the fourth quarter. SRS Capital Advisors Inc. now owns 1,593 shares of the company’s stock valued at $43,000 after buying an additional 1,220 shares during the period. Hilltop National Bank grew its position in Stevanato Group by 34.3% during the second quarter. Hilltop National Bank now owns 4,395 shares of the company’s stock valued at $81,000 after buying an additional 1,122 shares during the period. PNC Financial Services Group Inc. grew its position in Stevanato Group by 54.2% during the fourth quarter. PNC Financial Services Group Inc. now owns 3,089 shares of the company’s stock valued at $84,000 after buying an additional 1,086 shares during the period. Fifth Third Bancorp grew its position in Stevanato Group by 62.1% during the fourth quarter. Fifth Third Bancorp now owns 4,009 shares of the company’s stock valued at $109,000 after buying an additional 1,536 shares during the period. Finally, First Horizon Advisors Inc. grew its position in Stevanato Group by 14.1% during the fourth quarter. First Horizon Advisors Inc. now owns 5,311 shares of the company’s stock valued at $145,000 after buying an additional 657 shares during the period.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.